Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 55, Issue 4, 2014, Pages 899-910

  Patel, Viralkumar ^a,b   Chen, Lisa S ^a   Wierda, William G ^a   Balakrishnan, Kumudha ^a   Gandhi, Varsha ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Bcl 2 family members; Chronic lymphocytic leukemia; Microarray; Microenvironment; MRNA

Indexed keywords

BH3 PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN BCL 2; PROTEIN BCL B; PROTEIN BOK; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MICROFLUIDICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RNA SYNTHESIS; STROMA CELL; TUMOR MICROENVIRONMENT; GENE EXPRESSION PROFILING; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

APOPTOSIS; CELL SURVIVAL; COCULTURE TECHNIQUES; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MESENCHYMAL STROMAL CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84904355799     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.819573     Document Type: Article

References (46)

1. Schimmer AD, Munk-Pedersen I, Minden MD, et al. Bcl-2 and apoptosis in chronic lymphocytic leukemia. Curr Treat Options Oncol 2003;4:211-218.
2. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102: 13944-13949. (Pubitemid 41377683)
3. Kitada S, Andersen J, Akar S, et al. Expression of apoptosis- regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998;91:3379-3389. (Pubitemid 28193890)
4. Kitada S, Reed JC. MCL-1 promoter insertions dial-up aggressiveness of chronic leukemia. J Natl Cancer Inst 2004;96:642-643. (Pubitemid 38660217)
5. Tse C, Shoemaker AR, Adickes J, et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 2008;68: 3421-3428.
6. Balakrishnan K, Burger JA, Wierda WG, et al. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. Blood 2009;113:149-153.
7. Burger M, Hartmann T, Krome M, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005; 106: 1824-1830. (Pubitemid 41208600)
8. Longo PG, Laurenti L, Gobessi S, et al. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 2008; 111: 846-855.
9. Petlickovski A, Laurenti L, Li X, et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood 2005; 105: 4820-4827. (Pubitemid 40807309)
10. Balakrishnan K, Burger JA, Quiroga MP, et al. Influence ofbone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells. Blood 2010;116:1083-1091.
11. Burger JA, Tsukada N, Burger M, et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.Blood 2000; 96: 2655-2663.
12. Pedersen IM, Kitada S, Leoni LM, et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2002; 100: 1795-1801. (Pubitemid 34925159)
13. VoglerM, Butterworth M, Majid A, et al. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood 2009;113:4403-4413.
14. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival.Science 1998; 281: 1322-1326.
15. Del Gaizo Moore V, Letai A. BH3 profiling-measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett 2012; 332: 202-205.
16. Sanz L, Garcia-Marco JA, Casanova B, et al. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Biochem Biophys Res Commun 2004; 315: 562-567. (Pubitemid 38229380)
17. McConkey DJ, Chandra J, Wright S, et al. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol 1996; 156: 2624-2630. (Pubitemid 26091593)
18. Veis DJ, Sorenson CM, Shutter JR, et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229-240. (Pubitemid 23320287)
19. MaA, PenaJC, Chang B, et al. Bclxregulates the survival of double- positive thymocytes. Proc Natl Acad Sci USA 1995; 92: 4763-4767.
20. Opferman JT, Iwasaki H, Ong CC, et al. Obligate role of anti- apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005; 307: 1101-1104. (Pubitemid 40262114)
21. Opferman JT, Letai A, Beard C, et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003; 426: 671-676. (Pubitemid 38009376)
22. Zhou P, Levy NB, Xie H, et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 2001; 97: 3902-3909.
23. Olsson A, Norberg M, Okvist A, et al. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer 2007;97:769-777. (Pubitemid 47396296)
24. Print CG, Loveland KL, Gibson L, et al. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci USA 1998; 95: 12424-12431. (Pubitemid 28483781)
25. Pepper C, Lin TT, Pratt G, et al. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 2008;112:3807-3817.
26. Lazaridou A, Miraxtsi C, Korantzis J, et al. Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH): relation to disease status. Leuk Lymphoma 2000; 36: 503-512. (Pubitemid 30103175)
27. Kuwana T, Mackey MR, Perkins G, et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002; 111: 331-342. (Pubitemid 35341388)
28. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730. (Pubitemid 32385543)
29. Antonsson B, Conti F, Ciavatta A, et al. Inhibition of Bax channel- forming activity by Bcl-2. Science 1997;277:370-372. (Pubitemid 27450709)
30. Knudson CM, Tung KS, Tourtellotte WG, et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96-99.
31. Takeuchi O, Fisher J, Suh H, et al. Essential role of BAX, BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci USA 2005; 102: 11272-11277. (Pubitemid 41153810)
32. Zinkel SS, Ong CC, Ferguson DO, et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev 2003; 17: 229-239. (Pubitemid 36105895)
33. Bouillet P, Metcalf D, Huang DC, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.Science 1999; 286: 1735-1738. (Pubitemid 129515880)
34. Bouillet P, Purton JF, Godfrey DI, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922-926. (Pubitemid 34174755)
35. Villunger A, Scott C, Bouillet P, et al. Essential role for the BH3- only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood 2003;101:2393-2400. (Pubitemid 36302087)
36. Fischer SF, Bouillet P, O'Donnell K, Light A, Tarlinton DM, Strasser A. Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood 2007;110: 3978-3984. (Pubitemid 350248453)
37. Ranger AM, Zha J, Harada H, et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003;100: 9324-9329. (Pubitemid 37033927)
38. Hamilton E, Pearce L, Morgan L, et al. Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells. Br J Haematol 2012; 158: 589-599.
39. Davids MS, Deng J, Wiestner A, et al. Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia. Blood 2012; 120: 3501-3509.
40. Willimott S, Baou M, Naresh K, et al. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. Br J Haematol 2007;138:721-732. (Pubitemid 47313210)
41. Kay NE, Shanafelt TD, Strege AK, et al. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch'! Leuk Res 2007;31:899-906. (Pubitemid 46856727)
42. Correia AL, BissellMJ. The tumormicroenvironmentis a dominant force in multidrug resistance. Drug Resist Updat 2012; 15: 39-49.
43. Buggins AG, Pepper C, Patten PE, et al. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Cancer Res 2010; 70: 7523-7533.
44. Del Gaizo Moore V, Brown JR, Certo M, et al. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest 2007;117: 112-121. (Pubitemid 46048458)
45. Starczynski J, Pepper C, Pratt G, et al. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukemia once treatment is initiated.J Clin Oncol 2005; 23: 1514-1521.
46. Gandhi V Balakrishnan K, Chen LS. Mcl-1: the 1 in CLL. Blood 2008; 112: 3538-3540.